Dimethyl fumarate: updated advice on the risk of PML associated with mild lymphopenia

The monitoring requirements and discontinuation criteria for dimethyl fumarate (Tecfidera) have been strengthened following a small number of reports of progressive multifocal leukoencephalopathy (PML) in patients with mild lymphopenia.

Please sign in or register for FREE

No comments yet.